Immunovant Q1 2026 Earnings Wider Than Expected Loss Amid No Revenue SPOT Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress NSA Q1 2026 Earnings EPS Beats Estimates by 56 Amid Steady SelfStorage Fundamentals PSQH Q1 2026 Earnings Narrower Loss Beats Estimates as Stock Declines National Grid Q1 2026 Earnings EPS Misses Estimates as Utility Sector Faces Headwinds